Spots Global Cancer Trial Database for etoposide phosphate

Every month we try and update this database with for etoposide phosphate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors	NCT00303849	Anaplastic Olig... Anaplastic Olig... Mixed Glioma Oligoastrocytom...	Carboplatin Etoposide Etoposide Phosp... Laboratory Biom... Mannitol Melphalan Quality-of-Life... Sodium Thiosulf...	18 Years - 75 Years	OHSU Knight Cancer Institute
Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors	NCT00075387	Malignant Gliom...	Carboplatin Cyclophosphamid... Etoposide Phosp... Quality-of-Life... Sodium Thiosulf...	18 Years - 75 Years	OHSU Knight Cancer Institute
Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma	NCT00410631	Neuroblastoma	filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... conventional su... peripheral bloo... iobenguane I 13... radiation thera...	- 21 Years	National Cancer Institute (NCI)
Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain	NCT00293358	Brain and Centr...	carboplatin cisplatin etoposide phosp... ifosfamide adjuvant therap... conventional su... neoadjuvant the... radiation thera...	-	National Cancer Institute (NCI)
Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT01256398	Acute Lymphobla... Adult B Acute L...	Alemtuzumab Allogeneic Hema... Autologous Hema... Cyclophosphamid... Cytarabine Dasatinib Daunorubicin Hy... Dexamethasone Etoposide Phosp... Filgrastim Fludarabine Pho... In Vitro-Treate... Laboratory Biom... Leucovorin Calc... Melphalan Mercaptopurine Methotrexate Pegfilgrastim Pharmacological... Tacrolimus Vincristine Sul...	18 Years -	National Cancer Institute (NCI)
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors	NCT01042522	Ovarian Granulo... Ovarian Gynandr... Ovarian Sertoli... Ovarian Sex Cor... Ovarian Sex Cor... Ovarian Sex Cor... Ovarian Steroid...	Bleomycin Sulfa... Carboplatin Cisplatin Etoposide Phosp... Laboratory Biom... Paclitaxel	18 Years -	GOG Foundation
Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer	NCT00433498	Lung Cancer	carboplatin cisplatin etoposide phosp... pravastatin sod...	18 Years -	University College, London
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors	NCT02375204	Germ Cell Tumor Teratoma Choriocarcinoma Germinoma Mixed Germ Cell... Yolk Sac Tumor Childhood Terat... Malignant Germ ... Extragonadal Se... Non-seminomatou... Seminoma	paclitaxel ifosfamide cisplatin pegylated G-CSF G-CSF carboplatin etoposide phosp... stem cell reinf...	14 Years -	Alliance for Clinical Trials in Oncology
Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors	NCT00301782	Extragonadal Ge... Teratoma Testicular Germ...	bleomycin sulfa... carboplatin cisplatin etoposide phosp... vincristine sul...	16 Years -	National Cancer Institute (NCI)
Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma	NCT00974792	Lymphoma	pegfilgrastim rituximab cyclophosphamid... cytarabine doxorubicin hyd... etoposide phosp... ifosfamide leucovorin calc... methotrexate vincristine sul...	18 Years - 60 Years	National Cancer Institute (NCI)
Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer	NCT00433498	Lung Cancer	carboplatin cisplatin etoposide phosp... pravastatin sod...	18 Years -	University College, London
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors	NCT01042522	Ovarian Granulo... Ovarian Gynandr... Ovarian Sertoli... Ovarian Sex Cor... Ovarian Sex Cor... Ovarian Sex Cor... Ovarian Steroid...	Bleomycin Sulfa... Carboplatin Cisplatin Etoposide Phosp... Laboratory Biom... Paclitaxel	18 Years -	GOG Foundation
Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma	NCT00526318	Neuroblastoma	filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... iobenguane I 13... radiation thera...	- 21 Years	National Cancer Institute (NCI)
Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia	NCT03983824	Recurrent Acute... Refractory Acut...	Cytarabine Etoposide Phosp... Mitoxantrone Hy... Peposertib	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma	NCT01026220	Childhood Nodul... Stage III Child... Stage IV Childh...	bleomycin sulfa... doxorubicin hyd... liposomal vincr... vinorelbine tar... cyclophosphamid... etoposide phosp... prednisone filgrastim ifosfamide	- 21 Years	Children's Oncology Group
Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma	NCT00002880	Lymphoma	Etoposide phosp...	-	Alliance for Clinical Trials in Oncology
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab	NCT05675410	Lugano Classifi...	Biospecimen Col... Bleomycin Sulfa... Brentuximab Ved... Computed Tomogr... Cyclophosphamid... Dacarbazine Doxorubicin Hyd... Etoposide Etoposide Phosp... Fludeoxyglucose... Involved-site R... Magnetic Resona... Nivolumab Positron Emissi... Prednisolone Prednisone Procarbazine Hy... Questionnaire A... Vinblastine Sul... Vincristine Sul...	5 Years - 60 Years	National Cancer Institute (NCI)
Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma	NCT00002880	Lymphoma	Etoposide phosp...	-	Alliance for Clinical Trials in Oncology
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	NCT00873093	B-cell Adult Ac... B-cell Childhoo... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... T-cell Adult Ac... T-cell Childhoo...	L-asparaginase doxorubicin hyd... therapeutic hyd... vincristine sul... cytarabine prednisone bortezomib pegaspargase methotrexate etoposide phosp... cyclophosphamid... filgrastim leucovorin calc... laboratory biom... High Dose MTX	1 Year - 31 Years	National Cancer Institute (NCI)
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma	NCT00017368	Neuroblastoma	filgrastim sargramostim carboplatin cisplatin cyclophosphamid... doxorubicin hyd... etoposide etoposide phosp... ifosfamide isotretinoin melphalan thiotepa vincristine sul... conventional su... peripheral bloo... radiation thera...	- 30 Years	Children's Oncology Group
Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma	NCT00317408	Lymphoma	anti-thymocyte ... busulfan carboplatin carmustine cyclosporine cytarabine dexamethasone etoposide phosp... idarubicin ifosfamide leucovorin calc... lomustine melphalan methotrexate mitoxantrone hy... prednisolone thiotepa vinblastine sul... vindesine allogeneic hema... autologous hema... peripheral bloo... total-body irra...	- 21 Years	National Cancer Institute (NCI)
Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma	NCT00317408	Lymphoma	anti-thymocyte ... busulfan carboplatin carmustine cyclosporine cytarabine dexamethasone etoposide phosp... idarubicin ifosfamide leucovorin calc... lomustine melphalan methotrexate mitoxantrone hy... prednisolone thiotepa vinblastine sul... vindesine allogeneic hema... autologous hema... peripheral bloo... total-body irra...	- 21 Years	National Cancer Institute (NCI)
Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen	NCT00074165	Brain and Centr... Drug/Agent Toxi... Lymphoma Thrombocytopeni...	Rituxan Cyclophosphamid... Etoposide Etoposide phosp... Carboplatin Sodium thiosulf... Neupogen Neulasta Cytarabine	18 Months - 75 Years	OHSU Knight Cancer Institute
Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System	NCT00867178	Medulloblastoma Pineoblastoma Supratentorial ...	3-Dimensional C... Carboplatin Cisplatin Cyclophosphamid... Etoposide Phosp... Isotretinoin Laboratory Biom... Peripheral Bloo... Thiotepa Vincristine Sul... Vorinostat	2 Months - 47 Months	National Cancer Institute (NCI)
Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma	NCT00074178	Lymphoma	filgrastim pegfilgrastim cyclophosphamid... cytarabine dexamethasone etoposide phosp... methotrexate	16 Years - 75 Years	OHSU Knight Cancer Institute
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma	NCT00005792	Multiple Myelom... Plasma Cell Neo...	etoposide phosp... melphalan topotecan Autologous Stem...	15 Years - 69 Years	H. Lee Moffitt Cancer Center and Research Institute
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma	NCT02306161	Metastatic Ewin... Metastatic Mali... Metastatic Mali... Metastatic Mali... Metastatic Peri... Peripheral Prim...	Cyclophosphamid... Doxorubicin Doxorubicin Hyd... Etoposide Etoposide Phosp... External Beam R... Ganitumab Ifosfamide Stereotactic Ra... Therapeutic Sur... Vincristine Vincristine Sul...	- 50 Years	National Cancer Institute (NCI)
Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma	NCT03440567	Recurrent Diffu... Recurrent Mantl... Refractory Diff... Refractory Mant... Transformed Fol...	Autologous Hema... Avelumab Carboplatin Etoposide Phosp... Ibrutinib Ifosfamide Laboratory Biom... Rituximab Utomilumab	18 Years -	City of Hope Medical Center
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma	NCT01026220	Childhood Nodul... Stage III Child... Stage IV Childh...	bleomycin sulfa... doxorubicin hyd... liposomal vincr... vinorelbine tar... cyclophosphamid... etoposide phosp... prednisone filgrastim ifosfamide	- 21 Years	Children's Oncology Group
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT01005758	Leukemia	cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide phosp... hydrocortisone ... imatinib mesyla... mercaptopurine methotrexate methylprednisol... pegaspargase prednisolone prednisone vincristine sul... laboratory biom... radiation thera...	18 Years - 50 Years	National Cancer Institute (NCI)
Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma	NCT03440567	Recurrent Diffu... Recurrent Mantl... Refractory Diff... Refractory Mant... Transformed Fol...	Autologous Hema... Avelumab Carboplatin Etoposide Phosp... Ibrutinib Ifosfamide Laboratory Biom... Rituximab Utomilumab	18 Years -	City of Hope Medical Center
Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma	NCT02106988	Lymphoma	Radiation Thera... Dexamethasone Etoposide phosp... Ifosfamide Mesna Carboplatin	18 Years -	M.D. Anderson Cancer Center
Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma	NCT00974792	Lymphoma	pegfilgrastim rituximab cyclophosphamid... cytarabine doxorubicin hyd... etoposide phosp... ifosfamide leucovorin calc... methotrexate vincristine sul...	18 Years - 60 Years	National Cancer Institute (NCI)
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma	NCT01132807	Lymphoma	Bleomycin Sulfa... Doxorubicin Hyd... Procarbazine Hy... Vinblastine Sul... Dacarbazine Cyclophosphamid... Etoposide phosp... prednisone Radiation Thera... Fludeoxyglucose... computed tomogr... Positron Emissi...	18 Years - 60 Years	Alliance for Clinical Trials in Oncology
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma	NCT02306161	Metastatic Ewin... Metastatic Mali... Metastatic Mali... Metastatic Mali... Metastatic Peri... Peripheral Prim...	Cyclophosphamid... Doxorubicin Doxorubicin Hyd... Etoposide Etoposide Phosp... External Beam R... Ganitumab Ifosfamide Stereotactic Ra... Therapeutic Sur... Vincristine Vincristine Sul...	- 50 Years	National Cancer Institute (NCI)
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	NCT00873093	B-cell Adult Ac... B-cell Childhoo... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... T-cell Adult Ac... T-cell Childhoo...	L-asparaginase doxorubicin hyd... therapeutic hyd... vincristine sul... cytarabine prednisone bortezomib pegaspargase methotrexate etoposide phosp... cyclophosphamid... filgrastim leucovorin calc... laboratory biom... High Dose MTX	1 Year - 31 Years	National Cancer Institute (NCI)
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors	NCT02375204	Germ Cell Tumor Teratoma Choriocarcinoma Germinoma Mixed Germ Cell... Yolk Sac Tumor Childhood Terat... Malignant Germ ... Extragonadal Se... Non-seminomatou... Seminoma	paclitaxel ifosfamide cisplatin pegylated G-CSF G-CSF carboplatin etoposide phosp... stem cell reinf...	14 Years -	Alliance for Clinical Trials in Oncology
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors	NCT02375204	Germ Cell Tumor Teratoma Choriocarcinoma Germinoma Mixed Germ Cell... Yolk Sac Tumor Childhood Terat... Malignant Germ ... Extragonadal Se... Non-seminomatou... Seminoma	paclitaxel ifosfamide cisplatin pegylated G-CSF G-CSF carboplatin etoposide phosp... stem cell reinf...	14 Years -	Alliance for Clinical Trials in Oncology
Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies	NCT01900509	Hodgkin Lymphom... Non-Hodgkin Lym... Acute Leukemia	Bendamustine Clofarabine Etoposide Etoposide phosp... Dexamethasone	- 21 Years	St. Jude Children's Research Hospital
Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT01256398	Acute Lymphobla... Adult B Acute L...	Alemtuzumab Allogeneic Hema... Autologous Hema... Cyclophosphamid... Cytarabine Dasatinib Daunorubicin Hy... Dexamethasone Etoposide Phosp... Filgrastim Fludarabine Pho... In Vitro-Treate... Laboratory Biom... Leucovorin Calc... Melphalan Mercaptopurine Methotrexate Pegfilgrastim Pharmacological... Tacrolimus Vincristine Sul...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma	NCT00526318	Neuroblastoma	filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... iobenguane I 13... radiation thera...	- 21 Years	National Cancer Institute (NCI)
Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer	NCT00897871	Unspecified Chi...	carboplatin cyclophosphamid... etoposide phosp... gene expression... polymorphism an... pharmacological...	- 2 Years	National Cancer Institute (NCI)
Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma	NCT02137096	Recurrent Nasop...	Etoposide phosp... Carboplatin Ifosfamide Autologous Stem...	2 Years - 30 Years	University of Florida
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy	NCT01871766	Rhabdomyosarcom...	Vincristine Dactinomycin Cyclophosphamid... Surgical Resect... Radiation Bevacizumab Sorafenib Myeloid Growth ... Lymph Node Samp... Irinotecan Ifosfamide Etoposide Etoposide Phosp... Doxorubicin Dexrazoxane ^1^1C-methionin...	- 21 Years	St. Jude Children's Research Hospital
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT01005758	Leukemia	cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide phosp... hydrocortisone ... imatinib mesyla... mercaptopurine methotrexate methylprednisol... pegaspargase prednisolone prednisone vincristine sul... laboratory biom... radiation thera...	18 Years - 50 Years	National Cancer Institute (NCI)
Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors	NCT00303849	Anaplastic Olig... Anaplastic Olig... Mixed Glioma Oligoastrocytom...	Carboplatin Etoposide Etoposide Phosp... Laboratory Biom... Mannitol Melphalan Quality-of-Life... Sodium Thiosulf...	18 Years - 75 Years	OHSU Knight Cancer Institute
Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer	NCT00011921	Lung Cancer	filgrastim carboplatin epirubicin hydr... etoposide etoposide phosp... ifosfamide paclitaxel autologous bone... bone marrow abl... peripheral bloo... radiation thera...	- 65 Years	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant	NCT00417053	Neuroblastoma	filgrastim busulfan carboplatin cyclophosphamid... doxorubicin hyd... etoposide phosp... melphalan vincristine sul... autologous bone... bone marrow abl... conventional su... peripheral bloo... radiation thera...	- 1 Year	National Cancer Institute (NCI)
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT	NCT01356290	Medulloblastoma... Ependymoma Recu... ATRT Recurrent	Bevacizumab Thalidomide Celecoxib Fenofibric acid Etoposide Cyclophosphamid... Etoposide phosp... Cytarabine	- 19 Years	Medical University of Vienna
Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin	NCT01175356	Ganglioneurobla... Localized Resec... Localized Unres... Regional Neurob... Stage 4 Neurobl... Stage 4S Neurob...	3-Dimensional C... Autologous Hema... Busulfan Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide Phosp... External Beam R... In Vitro-Treate... Intensity-Modul... Iobenguane I-13... Isotretinoin Laboratory Biom... Melphalan Pharmacological... Questionnaire A... Therapeutic Con... Topotecan Hydro... Vincristine Sul...	1 Year - 30 Years	Children's Oncology Group
Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia	NCT01249430	Recurrent Adult... Refractory Acut...	Azacitidine Cytarabine Etoposide Phosp... Laboratory Biom... Mitoxantrone Hy... Pharmacological...	18 Years - 70 Years	National Cancer Institute (NCI)
Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma	NCT00689845	Lymphoma	bleomycin sulfa... filgrastim rituximab cyclophosphamid... cytarabine doxorubicin hyd... etoposide phosp... ifosfamide methotrexate prednisolone prednisone vincristine sul... vindesine	18 Years -	National Cancer Institute (NCI)
Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma	NCT02137096	Recurrent Nasop...	Etoposide phosp... Carboplatin Ifosfamide Autologous Stem...	2 Years - 30 Years	University of Florida
Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia	NCT01249430	Recurrent Adult... Refractory Acut...	Azacitidine Cytarabine Etoposide Phosp... Laboratory Biom... Mitoxantrone Hy... Pharmacological...	18 Years - 70 Years	National Cancer Institute (NCI)
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT	NCT01356290	Medulloblastoma... Ependymoma Recu... ATRT Recurrent	Bevacizumab Thalidomide Celecoxib Fenofibric acid Etoposide Cyclophosphamid... Etoposide phosp... Cytarabine	- 19 Years	Medical University of Vienna
Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors	NCT00238173	Bone Marrow Sup... Brain and Centr... Drug/Agent Toxi... Long-term Effec...	filgrastim acetylcysteine carboplatin cyclophosphamid... etoposide phosp... mannitol sodium thiosulf...	1 Year - 18 Years	OHSU Knight Cancer Institute
Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer	NCT01160731	Lung Cancer	cisplatin etoposide phosp... panobinostat laboratory biom... pharmacological...	18 Years -	Cancer Trials Ireland
Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain	NCT00293358	Brain and Centr...	carboplatin cisplatin etoposide phosp... ifosfamide adjuvant therap... conventional su... neoadjuvant the... radiation thera...	-	National Cancer Institute (NCI)
Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer	NCT00897871	Unspecified Chi...	carboplatin cyclophosphamid... etoposide phosp... gene expression... polymorphism an... pharmacological...	- 2 Years	National Cancer Institute (NCI)
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas	NCT02130869	Neuroblastoma Lymphoma High-risk Tumor	CD133+ selected... IL-2 hu14.18K322A Busulfan Melphalan GM-CSF Bendamustine Etoposide Cytarabine Carboplatin Haploidentical ... G-CSF Etoposide phosp... CliniMACS	- 21 Years	St. Jude Children's Research Hospital
Testing of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide and Cisplatin) for Patients With NUT Carcinoma	NCT04116359	Metastatic NUT ... Unresectable NU...	Cisplatin Etoposide Etoposide Phosp... Molibresib Molibresib Besy...	12 Years -	National Cancer Institute (NCI)
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma	NCT05991388	B-cell Non Hodg...	Odronextamab Loncastuximab t... Rituximab Ifosfamide Carboplatin Etoposide Etoposide Phosp... Dexamethasone CAR T-cells (TB...	- 25 Years	University of Birmingham
Multicenter Study of Safety and Efficacy Nivolumab at the Fixed Dose 40 mg (Nivo40) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed PMBL	NCT06188676	Primary Mediast...	Cyclophosphamid... Doxorubicin Hyd... Etoposide Phosp... Prednisolone Rituximab Vincristine Sul... Filgrastim Pegfilgrastim Nivolumab 40 mg...	18 Years - 70 Years	National Research Center for Hematology, Russia

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: